Literature DB >> 24211845

Combination therapy with anti-CD6 and oral insulin immunization reverses recent onset diabetes in non obese diabetic mice but fails to induce lasting tolerance.

Darius A Schneider1, Ghanashyam Sarikonda, Enrique Montero, Matthias G von Herrath.   

Abstract

Entities:  

Keywords:  ALCAM; Antigen specific therapy; CD6; Immunization; Immunology; NOD; Oral insulin; Type 1 diabetes

Mesh：

Substances：

Year:  2013        PMID： 24211845     DOI： 10.1016/j.clim.2013.08.004

Source DB:  PubMed          Journal:  Clin Immunol        ISSN： 1521-6616            Impact factor:   3.969


× No keyword cloud information.
  4 in total

1.  DNA methylation and waist-to-hip ratio: an epigenome-wide association study in Chinese monozygotic twins.

Authors:  Y Wu; H Tian; W Wang; W Li; H Duan; D Zhang
Journal:  J Endocrinol Invest       Date:  2022-07-26       Impact factor: 5.467

2.  Shifts in the immunoepigenomic landscape of monocytes in response to a diabetes-specific social support intervention: a pilot study among Native Hawaiian adults with diabetes.

Authors:  Christian K Dye; Michael J Corley; Claire Ing; Annette Lum-Jones; Dongmei Li; Marjorie K L M Mau; Alika K Maunakea
Journal:  Clin Epigenetics       Date:  2022-07-18       Impact factor: 7.259

Review 3.  Type 1 diabetes mellitus and its oral tolerance therapy.

Authors:  Rui-Feng Mao; Ying-Ying Chen; Ji Zhang; Xin Chang; Ye-Fu Wang
Journal:  World J Diabetes       Date:  2020-10-15

4.  An Exploratory Study of Itolizumab on the Preservation of Beta Cell Function in Adults with Recent-Onset Type 1 Diabetes.

Authors:  Eduardo Cabrera-Rode; Ileana Cubas-Dueñas; Janet Rodríguez-Acosta; Yudith García-García; Yelena Torres-López; Claudia Prieto-Noa; Bárbara M Vázquez-Izada; Maité Ruíz-Reinoso; Ragmila Echevarría-Valdés; Aimee Álvarez-Álvarez; Emma Domínguez-Alonso; Ana Ibis Conesa-González; Teresa González-Calero; Erick Robles-Torres; Silvia Elena Turcios-Tristá; Elizabeth Senra-Estévez; Patricia Hernández-Casaña; Luis Sarmiento
Journal:  J Clin Med       Date:  2022-03-24       Impact factor: 4.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.